| Literature DB >> 29618979 |
Arilson F M de Sousa1, André R Medeiros1, Stefano Benitez-Flores1, Sebastián Del Rosso1, Matthew Stults-Kolehmainen2, Daniel A Boullosa1,3.
Abstract
This study aimed to: (1) investigate the influence of a 2-weeks sprint interval training (SIT) program on aerobic capacity, cardiac autonomic control, and components of attention in young healthy university students; and (2) to ascertain whether training fidelity would influence these adaptations. One hundred and nine participants were divided into an experimental (EG) and control (CG) groups. The EG performed a SIT program that consisted of 6 sessions of 4 × 30 s "all-out" efforts on a cycle ergometer, interspersed with active rests of 4 min. The criterion for fidelity was achieving >90% of estimated maximum heart rate (HR) during sprint bouts. After analyses, the EG was divided into HIGH (n = 26) and LOW (n = 46) fidelity groups. Components of attention were assessed using the Attention Network Test (ANT). Aerobic capacity (VO2max) was estimated while the sum of skinfolds was determined. Autonomic control of HR was assessed by means of HR variability (HRV) and HR complexity at rest and during ANT. Both HIGH and LOW significantly increased aerobic capacity, vagal modulation before and during ANT, and executive control, and decreased body fatness after SIT (p < 0.05). However, only participants from HIGH showed an increase in HR complexity and accuracy in ANT when compared to LOW (p < 0.05). Two weeks of SIT improved executive control, body fatness, aerobic fitness, and autonomic control in university students with better results reported in those individuals who exhibited high fidelity.Entities:
Keywords: aerobic fitness; cognition; executive control; high intensity interval training; vagal withdrawal
Year: 2018 PMID: 29618979 PMCID: PMC5871711 DOI: 10.3389/fphys.2018.00241
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Participants' characteristics of HIGH, LOW, and CG after analysis of fidelity.
| Age (years) | 23.08 ± 3.96 | 23.79 ± 6.09 | 24.12 ± 5.94 | 22.67 ± 3.80 | 25.07 ± 4.27 | 24.33 ± 4.69 |
| METs (MET-min/week) | 2,045 ± 1,184 | 1,329 ± 1,061 | 2,447 ± 1,544 | 1,768 ± 1,459 | 1,562 ± 1,440 | 1,692 ± 1,124 |
| TV (min/week) | 1,530 ± 1,304 | 2,193 ± 1,601 | 967 ± 955 | 1,859.1,152 | 1,167 ± 1,286 | 1,860 ± 1,213 |
HIGH, high fidelity group; LOW, low fidelity group; CG, control group; METs, MET-min per week: MET level x minutes of activity x events per week (IPAQ), TV (min/week), minutes on screen per week (IPAQ). Data are mean ± SD.
p < 0.05 different from males of the same group.
Figure 1Examples of fidelity analyses with one female participant (20 years old) who achieved the target heart rate (90% of maximum heart rate) during a session (Left), and another female participant of the same age who did not achieve the same target heart rate during the same session (Right).
Body composition, VO2max and HRV measures at rest before and after SIT in HIGH, LOW, and CG.
| BMI (kg·m−2) | 24.5 ± 3.4 | 24.5 ± 3.4 | 0.00 | 25.0 ± 4.4 | 25.1 ± 4.4 | 0.00 | 23.7 ± 3.9 | 23.6 ± 3.9 | 0.00 |
| SS (mm) | 148 ± 48 | 146 ± 48 | 0.04 | 144 ± 58 | 142 ± 58 | 0.03 | 124 ± 48 | 124 ± 48 | 0.00 |
| VO2max (mL·kg−1·min−1) | 36.9 ± 8.6 | 41.5 ± 6.4 | 0.63 | 38.7 ± 9.1 | 43.5 ± 9.7 | 0.51 | 37.9 ± 8.9 | 38.5 ± 9.5 | 0.07 |
| HR (average) | 141.4 ± 12 | 133.0 ± 9.4 | 0.71 | 137.1 ± 11.4 | 130.3 ± 9.4 | 0.65 | 139 ± 9.9 | 134.9 ± 7.9 | 0.40 |
VO.
p ≤ 0.05 effect of time, d = Cohen's d (effect size).
Attention components before and after SIT during the ANT in HIGH, LOW and CG.
| ALERT (ms) | 39.3 ± 24.8 | 39.9 ± 20.7 | 0.03 | 41.3 ± 24.4 | 42.1 ± 24.7 | 0.03 | 49.3 ± 20.8 | 54.2 ± 18.8 | 0.25 |
| ORIENTING (ms) | 41.8 ± 28.8 | 45.9 ± 18.2 | 0.17 | 35.4 ± 25.6 | 36.3 ± 17.9 | 0.04 | 37.7 ± 22.5 | 39.8 ± 21.3 | 0.10 |
| CONFLICT (ms) | 152.5 ± 63.3 | 121.7 ± 44.7 | 0.56 | 131.2 ± 48.9 | 106.97 ± 36.79 | 0.56 | 129.4 ± 37.7 | 121.3 ± 30.7 | 0.24 |
| RT (ms) | 668.7 ± 85.1 | 665.6 ± 84.7 | 0.03 | 726.6 ± 109.9 | 707.31 ± 82.95 | 0.20 | 679.0 ± 66.8 | 663.5 ± 56.8 | 0.25 |
| ACC (%) | 96.2 ± 6.5 | 98.5 ± 2.6 | 0.48 | 95.3 ± 11.7 | 94.38 ± 12.5 | 0.08 | 98.3 ± 1.8 | 97.7 ± 3.9 | 0.20 |
SIT, sprint interval training; ANT, attention network test; HIGH, high fidelity group; CG, control group; ALERT, alerting component in the ANT test; ORIENTING, orienting component in the ANT test; CONFLICT, conflict effect component in the ANT test; RT, reaction time in the ANT test; ACC, accuracy in the ANT test. Data are mean ± SD.
p ≤ 0.05 time effect, d = Cohen's d (effect size).
HRV measures at rest and the moments in the ANT before and after SIT in HIGH, LOW and Control Groups.
| Rest | 83 ± 10.1 | 76.3 ± 9.2 | −0.69 | 74.4 ± 13.1 | 73.2 ± 9.2 | −0.09 | 72.5 ± 11 | 73.±10.5 | 0.10 | |
| HR (bpm) | 1 | 83 ± 10.2 | 77.7 ± 8.7 | −0.56 | 75.3 ± 13 | 73.7 ± 11.7 | −0.13 | 73.6 ± 11.4 | 75.3 ± 11.4 | 0.15 |
| 2 | 83.6 ± 10.2 | 79.2 ± 9.2 | −0.46 | 76.3 ± 12.8 | 74.8 ± 12.2 | −0.12 | 73.8 ± 12 | 76.2 ± 11.4 | 0.20 | |
| 3 | 83.9 ± 10.5 | 78.9 ± 9 | −0.52 | 76.2 ± 12 | 75.3 ± 12.7 | −0.07 | 75 ± 11.9 | 75 ± 11.9 | 0.09 | |
| Rest | 31.8 ± 13.8 | 38.8 ± 18.6 | 0.43 | 44.3 ± 25.3 | 50.5 ± 28.6 | 0.23 | 46.4 ± 20.3 | 39.7 ± 16.1 | −0.37 | |
| RMSSD (ms) | 1 | 32.5 ± 16.8 | 38.9 ± 17.4 | 0.37 | 43.7 ± 23.8 | 49.2 ± 27.3 | 0.22 | 48.6 ± 22.1 | 40.4 ± 19.3 | −0.40 |
| 2 | 30.1 ± 14.3 | 37.5 ± 16.9 | 0.47 | 41.9 ± 21.7 | 48.4 ± 26.2 | 0.27 | 50.7 ± 25.2 | 40.6 ± 18.7 | −0.46 | |
| 3 | 30.3 ± 13.9 | 38.4 ± 17.8 | 0.51 | 43.8 ± 24.9 | 47.1 ± 26.6 | 0.13 | 46 ± 22 | 40.5 ± 18 | −0.27 | |
| Rest | 49.9 ± 16.4 | 54.8 ± 19.9 | 0.27 | 58.3 ± 26.6 | 67.8 ± 32.8 | 0.32 | 66.9 ± 20.8 | 63.2 ± 24.4 | −0.16 | |
| SDNN (ms) | 1 | 44.9 ± 13.9 | 52 ± 17.9 | 0.41 | 53.5 ± 23 | 61.6 ± 29.8 | 0.30 | 61.4 ± 20.9 | 58.3 ± 22.3 | −0.14 |
| 2 | 43.7 ± 15.3 | 55.7 ± 20.8 | 0.66 | 55.5 ± 22.8 | 65.9 ± 30.7 | 0.39 | 65.7 ± 24 | 64.6 ± 29.1 | −0.04 | |
| 3 | 47.8 ± 16.9 | 57 ± 19.8 | 0.50 | 58 ± 27.2 | 65.9 ± 31.1 | 0.27 | 67.2 ± 31.1 | 63 ± 21.8 | −0.16 | |
| Rest | 22.4 ± 9.7 | 27.9 ± 13.1 | 0.48 | 31.3 ± 18 | 35.8 ± 20.3 | 0.24 | 31.1 ± 14.7 | 27.3 ± 12.2 | −0.28 | |
| SD1 (ms) | 1 | 23.1 ± 11.9 | 27.6 ± 12.3 | 0.37 | 31 ± 16.8 | 34.8 ± 19.3 | 0.21 | 32.5 ± 16 | 27.5 ± 14.1 | −0.33 |
| 2 | 21.4 ± 10 | 26.6 ± 11.7 | 0.48 | 29.7 ± 15.4 | 34.3 ± 18.6 | 0.27 | 35.9 ± 17.8 | 28.7 ± 13.3 | −0.46 | |
| 3 | 21.3 ± 9.7 | 27.3 ± 13.1 | 0.52 | 31 ± 17.6 | 33.4 ± 18.8 | 0.13 | 32.6 ± 15.6 | 28.7 ± 12.8 | −0.27 | |
| Rest | 67.9 ± 21.5 | 75.8 ± 32 | 0.29 | 75.8 ± 34.3 | 88.4 ± 43 | 0.32 | 88 ± 26.7 | 82.5 ± 36.9 | −0.17 | |
| SD2 (ms) | 1 | 57.9 ± 17.5 | 67.7 ± 23.5 | 0.47 | 68.7 ± 28.9 | 79.5 ± 38.1 | 0.32 | 78.3 ± 25.4 | 75.4 ± 29.2 | −0.10 |
| 2 | 57.9 ± 19.9 | 74.6 ± 27.4 | 0.70 | 72.4 ± 29.4 | 86.1 ± 40.3 | 0.39 | 83.2 ± 30.8 | 86.5 ± 39.4 | 0.09 | |
| 3 | 63.9 ± 22.6 | 75.6 ± 24.6 | 0.50 | 75.4 ± 35.0 | 86.5 ± 40.6 | 0.29 | 87.5 ± 41.1 | 84.1 ± 28.4 | −0.10 | |
| Rest | 1.35 ± 0.24 | 1.43 ± 0.28 | 0.31 | 1.54 ± 0.27 | 1.47 ± 0.35 | −0.22 | 1.41 ± 0.39 | 1.4 ± 0.28 | −0.03 | |
| SampEn | 1 | 1.54 ± 0.33 | 1.62 ± 0.28 | 0.26 | 1.67 ± 0.22 | 1.59 ± 0.31 | −0.31 | 1.56 ± 0.32 | 1.49 ± 0.29 | −0.23 |
| 2 | 1.54 ± 0.27 | 1.6 ± 0.49 | 0.1 | 1.57 ± 0.28 | 1.51 ± 0.34 | −0.19 | 1.61 ± 0.3 | 1.45 ± 0.25 | −0.58 | |
| 3 | 1.44 ± 0.27 | 1.51 ± 0.27 | 0.26 | 1.57 ± 0.25 | 1.5 ± 0.3 | −0.25 | 1.5 ± 0.21 | 1.45 ± 0.23 | −0.23 | |
| Rest | 2.44 ± 1.25 | 2.95 ± 1.27 | 0.41 | 2.98 ± 1.35 | 2.79 ± 1.39 | −0.14 | 3.02 ± 1.11 | 3.02 ± 1.16 | 0 | |
| D2 | 1 | 2.63 ± 1.43 | 3.05 ± 1.43 | 0.29 | 2.87 ± 1.57 | 3.03 ± 1.45 | 0.11 | 3.27 ± 1.06 | 3.05 ± 1.23 | −0.19 |
| 2 | 2.66 ± 1.52 | 2.91 ± 1.28 | 0.18 | 2.84 ± 1.39 | 2.87 ± 1.35 | 0.02 | 3.13 ± 0.96 | 3.11 ± 1.29 | −0.02 | |
| 3 | 2.64 ± 1.49 | 3 ± 1.13 | 0.27 | 2.75 ± 1.46 | 3.02 ± 1.28 | 0.20 | 3.26 ± 1.16 | 3.2 ± 1.05 | −0.05 | |
HR, heart rate; SDNN, standard deviation of R-R intervals; RMSSD, root mean square of the successive differences between adjacent normal R-R intervals; HRV, heart rate variability; SIT, sprint interval training; HIGH, high fidelity group; LOW, low fidelity group; CG, control group; SD1, short-term beat-to-beat R-R variability from the Poincaré plot; SD2, long-term beat-to-beat variability from the Poincaré plot, SampEn, sample entropy; D2, correlation dimension. Data are mean ± SD.
p < 0.05 time effect,
p < 0.05 HIGH vs. LOW, d = Cohen's d (effect size).